Lithuania’s healthcare and Life Sciences sector is enjoying an ever-increasing role in the national economy. Today, it accounts for roughly four percent of the GDP, with a somewhat surprising one

At one of the most important events in the Lithuanian pharmaceutical industry, the Healthcare Innovation Forum, health policymakers, scientists, representatives of the pharmaceutical industry, doctors, representatives of public institutions and

Her commentary “Fight against falsified medicines: relevant medicine control developments” was published in the daily Lietuvos žinios. “One of the essential innovations is a unique identifier on the ingredients (with

“The Lithuanian decision makers must first set clear priorities for the future five, 10 and 15 years in advance, priorities that focus on the reversal of the Lithuanian healthcare specialist

Rūta Pumputienė, Head of the Local American Working Group (LAWG), during the interview with PharmaBoardroom, explained the main dynamics impacting the pharmaceutical sector in general, as well as the key

After the report released by the Ministry of Health on the growing budget for the Compulsory Health Insurance, R. Pumputienė has identified the problems that require the attention of policymakers.

The review presents how the healthcare is organised and financed in Lithuania: the advertising of medical products; information on and off-labels; possibilities for collaborations between the pharmaceutical industry and healthcare

The lawyer and the Head of the Local American Working Group (LAWG), Rūta Pumputienė, identified three issues after being asked about the problems in the Lithuanian healthcare system. The first

The lawyer and the Head of the Local American Working Group (LAWG), Rūta Pumputienė, noted at the conference that so far, an outdated form of strategic planning has been seen